होम › मल्टीपल मायलोमा › कोलोराडो › Denver
Denver, CO में मल्टीपल मायलोमा क्लिनिकल ट्रायल
Denver (लगभग 30 मील के भीतर) की साइटों पर मल्टीपल मायलोमा के लिए 27 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute /ID# 280275, Denver
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
भर्ती जारीचरण 3
- Research Site, Denver
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute, Denver
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 3
- Colorado Blood Cancer Institute, Denver
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
भर्ती जारीचरण 1
- Research Site, Denver
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute, Denver
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 3
- Colorado Blood Cancer Institute, Denver
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
भर्ती जारीचरण 2/3
- Colorado Blood Cancer Institute /ID# 279080, Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
भर्ती जारीचरण 3
- CBCI, Colorado Blood Cancer Institute, Denver
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute (CBCI) at Presbyterian/ St. Luke's Medical Center, Denver
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Center, Denver
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 1/2
- Research Site, Denver
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
भर्ती जारीचरण 1/2
- Colorado Blood Cancer Institute/SCRI, Denver
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
भर्ती जारीचरण 1/2
- Research Site, Denver
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
भर्ती जारीचरण 3
- Research Site, Denver
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
भर्ती जारीचरण 1/2
- Colorado Blood Cancer Institute /ID# 273129, Denver
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
भर्ती जारीचरण 3
- Colorado Blood Cancer Institute, Denver
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
भर्ती जारीचरण 1/2
- Colorado Blood Cancer Institute/SCRI, Denver
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute /ID# 273751, Denver
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
भर्ती जारीचरण 2
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Center, Denver
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
भर्ती जारीचरण 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
भर्ती जारीचरण 1
- Colorado Blood Cancer Institute, Denver
अन्य शहरों में मल्टीपल मायलोमा ट्रायल
- New York City, NY60 अध्ययन
- Boston, MA42 अध्ययन
- Atlanta, GA41 अध्ययन
- Houston, TX38 अध्ययन
- Durham, NC37 अध्ययन
- Nashville, TN32 अध्ययन
- Rochester, MN24 अध्ययन
- St. Louis, MO24 अध्ययन
- Columbus, OH24 अध्ययन
- Baldwin Park, CA23 अध्ययन
- Chicago, IL22 अध्ययन
- Seattle, WA22 अध्ययन
Denver में अन्य अध्ययन
- मेटास्टेटिक कैंसर29 अध्ययन
- स्तन कैंसर28 अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर27 अध्ययन
- कोलोरैक्टल कैंसर23 अध्ययन
- प्रोस्टेट कैंसर19 अध्ययन
- मेलेनोमा19 अध्ययन
- कैंसर (सभी प्रकार)18 अध्ययन
- अंडाशय का कैंसर16 अध्ययन
- फेफड़ों का कैंसर16 अध्ययन
- एंडोमेट्रियल कैंसर15 अध्ययन
- नॉन-हॉजकिन लिम्फोमा14 अध्ययन
- अग्न्याशय का कैंसर13 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।